"Novartis‘ 2,500 sales reps should not be paid overtime because they are too rich and work independently like white-collar managers, according to a ruling that is being appealed by the Dept. of Labor. The DOL filed an amicus brief in the case earlier this month. The case is one of many in which pharma sales reps have argued that they are not really salespersons (who are exempt from certain labor laws) and should therefore be paid millions in back-pay for overtime."
Más...
No hay comentarios:
Publicar un comentario